MEPIVACAINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Mepivacaine Hydrochloride patents expire, and when can generic versions of Mepivacaine Hydrochloride launch?
Mepivacaine Hydrochloride is a drug marketed by Belmora Llc, Hospira Inc, Intl Medication Sys, and Watson Labs. and is included in six NDAs.
The generic ingredient in MEPIVACAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEPIVACAINE HYDROCHLORIDE?
- What are the global sales for MEPIVACAINE HYDROCHLORIDE?
- What is Average Wholesale Price for MEPIVACAINE HYDROCHLORIDE?
Summary for MEPIVACAINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 81 |
| Patent Applications: | 1,009 |
| DailyMed Link: | MEPIVACAINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MEPIVACAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Indiana University | Phase 4 |
| NorthShore University HealthSystem | Phase 4 |
| Johnny K. Lee | Phase 4 |
Medical Subject Heading (MeSH) Categories for MEPIVACAINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MEPIVACAINE HYDROCHLORIDE
US Patents and Regulatory Information for MEPIVACAINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belmora Llc | MEPIVACAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 083559-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | MEPIVACAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 088769-001 | Nov 20, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | MEPIVACAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 040806-001 | Apr 28, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Intl Medication Sys | MEPIVACAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 087509-001 | Oct 5, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Belmora Llc | MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN | levonordefrin; mepivacaine hydrochloride | INJECTABLE;INJECTION | 084850-002 | Oct 21, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | MEPIVACAINE HYDROCHLORIDE | mepivacaine hydrochloride | INJECTABLE;INJECTION | 088770-001 | Nov 20, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
